I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 17 studies | 42% ± 11% | |
| non-classical monocyte | 10 studies | 29% ± 16% | |
| macrophage | 10 studies | 23% ± 7% | |
| dendritic cell | 8 studies | 41% ± 27% | |
| conventional dendritic cell | 8 studies | 26% ± 15% | |
| monocyte | 8 studies | 22% ± 6% | |
| natural killer cell | 7 studies | 18% ± 3% | |
| B cell | 7 studies | 24% ± 9% | |
| endothelial cell | 7 studies | 22% ± 3% | |
| endothelial cell of lymphatic vessel | 6 studies | 18% ± 2% | |
| fibroblast | 6 studies | 19% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 19% ± 2% | |
| epithelial cell | 6 studies | 34% ± 17% | |
| classical monocyte | 5 studies | 29% ± 12% | |
| myeloid cell | 5 studies | 25% ± 10% | |
| squamous epithelial cell | 4 studies | 35% ± 23% | |
| basal cell | 4 studies | 18% ± 2% | |
| ciliated cell | 4 studies | 28% ± 15% | |
| microglial cell | 4 studies | 26% ± 7% | |
| naive B cell | 3 studies | 19% ± 4% | |
| abnormal cell | 3 studies | 21% ± 3% | |
| oligodendrocyte | 3 studies | 20% ± 3% |
